Quest Diagnostics (DGX) Short term Debt (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Short term Debt data on file, last reported at $503.0 million in Q1 2026.

• Quarterly Short term Debt rose 50200.0% year-over-year to $503.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $503.0 million (up 50200.0% YoY) and the FY2025 annual result came in at $504.0 million, down 16.28% from the prior year.
• Short term Debt steadied at $503.0 million in Q1 2026 per DGX's latest filing, from $504.0 million in the prior quarter.
• The five-year high for Short term Debt was $906.0 million in Q1 2024, with the low at $1.0 million in Q1 2025.
• Average Short term Debt over 5 years is $345.2 million, with a median of $503.0 million recorded in 2026.
• Year-over-year, Short term Debt plunged 99.89% in 2025 and surged 50200.0% in 2026.
• Quest Diagnostics' Short term Debt stood at $2.0 million in 2022, then soared by 15050.0% to $303.0 million in 2023, then surged by 98.68% to $602.0 million in 2024, then decreased by 16.28% to $504.0 million in 2025, then slipped by 0.2% to $503.0 million in 2026.
• Business Quant data shows DGX's Short term Debt at $503.0 million in Q1 2026, $504.0 million in Q4 2025, and $504.0 million in Q3 2025.